The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.

Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...

Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business. The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or ...

Labcorp Holdings Inc. , a global leader of innovative and comprehensive laboratory services, today announced results for the fourth quarter and full year ended December 31, 2025, and provided 2026 ...

CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The Flowflex® Plus RSV + Flu A/B + COVID 4-in-1 test is now available in Northeast Ohio ...

Ohio is a hotspot for respiratory illnesses, including COVID-19 and a new flu strain. Health officials advise staying home until you are fever-free for 24 hours and symptoms improve. COVID-19 ...

Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...

FDA-cleared test enables at-home detection of RSV, Flu A/B and COVID in adults and pediatric populations. SAN DIEGO, Jan. 23, 2026 /PRNewswire/ -- ACON Laboratories, Inc. today announced the retail ...

In a public health crisis, Tobi Solidum saw a business opportunity, and his company made millions from a Honolulu-funded program. Now he’s at the center of a public corruption scandal.

It's never a bad time to stock up.

Thrivent Large Cap Value Fund outperformed the Russell 1000 Value Index for the quarter and every quarter throughout the year ...

FDA clears 1st blood test for Alzheimer’s to help primary care clinicians assess cognitive decline without brain scans or lumbar punctures.